These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33252744)

  • 81. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Charge requirements for proton gradient-driven translocation of anthrax toxin.
    Brown MJ; Thoren KL; Krantz BA
    J Biol Chem; 2011 Jul; 286(26):23189-99. PubMed ID: 21507946
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis.
    Brézillon C; Haustant M; Dupke S; Corre JP; Lander A; Franz T; Monot M; Couture-Tosi E; Jouvion G; Leendertz FH; Grunow R; Mock ME; Klee SR; Goossens PL
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003455. PubMed ID: 25830379
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A receptor-based switch that regulates anthrax toxin pore formation.
    Pilpa RM; Bayrhuber M; Marlett JM; Riek R; Young JA
    PLoS Pathog; 2011 Dec; 7(12):e1002354. PubMed ID: 22174672
    [TBL] [Abstract][Full Text] [Related]  

  • 86. (19)F nuclear magnetic resonance and crystallographic studies of 5-fluorotryptophan-labeled anthrax protective antigen and effects of the receptor on stability.
    Chadegani F; Lovell S; Mullangi V; Miyagi M; Battaile KP; Bann JG
    Biochemistry; 2014 Feb; 53(4):690-701. PubMed ID: 24387629
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA.
    Chiang C; Bongiorni C; Perego M
    J Bacteriol; 2011 Jan; 193(1):52-62. PubMed ID: 20971911
    [TBL] [Abstract][Full Text] [Related]  

  • 88. CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells.
    Slater LH; Hett EC; Clatworthy AE; Mark KG; Hung DT
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9932-7. PubMed ID: 23716698
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen.
    Feld GK; Kintzer AF; Tang II; Thoren KL; Krantz BA
    J Mol Biol; 2012 Jan; 415(1):159-74. PubMed ID: 22063095
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes.
    Sergeeva OA; van der Goot FG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1279-1288. PubMed ID: 30610172
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
    Martchenko M; Jeong SY; Cohen SN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cellular and physiological effects of anthrax exotoxin and its relevance to disease.
    Lowe DE; Glomski IJ
    Front Cell Infect Microbiol; 2012; 2():76. PubMed ID: 22919667
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The unfolding story of anthrax toxin translocation.
    Thoren KL; Krantz BA
    Mol Microbiol; 2011 May; 80(3):588-95. PubMed ID: 21443527
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Two small c-type cytochromes affect virulence gene expression in Bacillus anthracis.
    Wilson AC; Hoch JA; Perego M
    Mol Microbiol; 2009 Apr; 72(1):109-23. PubMed ID: 19222757
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study.
    Ren G; Quispe J; Leppla SH; Mitra AK
    Structure; 2004 Nov; 12(11):2059-66. PubMed ID: 15530370
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.
    Lacy DB; Wigelsworth DJ; Melnyk RA; Harrison SC; Collier RJ
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13147-51. PubMed ID: 15326297
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A kinetic analysis of protein transport through the anthrax toxin channel.
    Basilio D; Kienker PK; Briggs SW; Finkelstein A
    J Gen Physiol; 2011 Jun; 137(6):521-31. PubMed ID: 21624946
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Anthrax toxin: pathologic effects on the cardiovascular system.
    Golden HB; Watson LE; Lal H; Verma SK; Foster DM; Kuo SR; Sharma A; Frankel A; Dostal DE
    Front Biosci (Landmark Ed); 2009 Jan; 14(6):2335-57. PubMed ID: 19273204
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death.
    Zhu PJ; Hobson JP; Southall N; Qiu C; Thomas CJ; Lu J; Inglese J; Zheng W; Leppla SH; Bugge TH; Austin CP; Liu S
    Bioorg Med Chem; 2009 Jul; 17(14):5139-45. PubMed ID: 19540764
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease.
    Pflughoeft KJ; Swick MC; Engler DA; Yeo HJ; Koehler TM
    J Bacteriol; 2014 Jan; 196(2):424-35. PubMed ID: 24214942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.